MwanzoOPL • ASX
add
Opyl Ltd
Bei iliyotangulia
$ 0.019
Bei za mwaka
$ 0.014 - $ 0.033
Thamani ya kampuni katika soko
2.75M AUD
Wastani wa hisa zilizouzwa
elfu 110.33
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
ASX
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (AUD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 167.72 | 37.65% |
Matumizi ya uendeshaji wa biashara | elfu 323.38 | 42.41% |
Mapato halisi | elfu -341.60 | 46.47% |
Kiwango cha faida halisi | -203.67 | 61.11% |
Mapato kwa kila hisa | — | — |
EBITDA | elfu -318.04 | 25.38% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (AUD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | elfu 329.55 | -43.64% |
Jumla ya mali | elfu 384.82 | -41.63% |
Jumla ya dhima | elfu 695.82 | -3.76% |
Jumla ya hisa | elfu -310.99 | — |
hisa zilizosalia | 170.80M | — |
Uwiano wa bei na thamani | ∞ | — |
Faida inayotokana na mali | -208.46% | — |
Faida inayotokana mtaji | -683.20% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (AUD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | elfu -341.60 | 46.47% |
Pesa kutokana na shughuli | elfu -309.99 | -6.88% |
Pesa kutokana na uwekezaji | -662.00 | — |
Pesa kutokana na ufadhili | elfu 288.10 | -19.06% |
Mabadiliko halisi ya pesa taslimu | elfu -22.55 | -134.21% |
Mtiririko huru wa pesa | elfu -200.74 | 18.01% |
Kuhusu
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Ilianzishwa
2013
Tovuti
Wafanyakazi
3
